Socioeconomic status may affect survival of patients with anal cancer

March 12, 2018, Wiley

In a study of patients with anal cancer, living in low median household income areas was linked with an increased risk of early death. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings suggest that socioeconomic inequalities may affect cancer outcomes, especially for highly treatable and curable tumors such as anal cancer.

Squamous cell carcinoma of the anus (SCCA) accounts for 8,200 new cancer cases and more than 1,000 cancer-related deaths in the United States annually. Its incidence has been notably rising in recent decades, possibly related to changing trends in sexual behavior combined with known risk factors, such as human papilloma virus and tobacco smoking. Although advances in the treatment of SCCA have improved survival and cure rates, the benefits may not be shared uniformly among patients of disparate .

To investigate, a team led by Daniel Becker, MD, of Perlmutter Cancer Center at NYU Langone Health examined whether area-based median household income predicts survival of patients with SCCA. Their analysis included 9,550 patients with SCCA from 2004-2013 listed in the US Surveillance, Epidemiology, and End Results registry. Socioeconomic status was defined by census-tract median household income level, and divided into quintiles.

The researchers found that patients living in areas with lower median household income had worse overall survival and cancer-specific survival compared with those in highest income areas. From the lowest to the higher income levels, the risk of dying was 32%, 31%, 19%, and 16% higher for patients when compared with patients in the very highest quintile of median household . When considering only deaths due to cancer, increased risks ranged from 34% down to 22% for the lowest to higher incomes. Other factors such as older age, black race, male gender, unmarried status, earlier year of diagnosis, higher grade, and later stage were also associated with worse cancer-specific survival. Income was not associated with a patient's likelihood of initiating radiation therapy.

"Our findings reveal that US residents who have anal cancer and live in areas of poverty have worse survival than those who live in more affluent areas, even after accounting for differences in age, stage, and race," said Dr. Becker. "Anal cancer is often a curable disease, and, in light of the tremendous resources available in US healthcare, we do not believe that poverty should determine cancer outcomes. The ultimate goal is to make sure that all receive high quality care, regardless of their wealth or zip code."

Dr. Becker noted that to provide high quality healthcare for all, it will be important to get a better understanding of the factors limiting the successful treatment of anal . "Additional resources are urgently needed to study and address disparities in care and outcomes."

Explore further: Study cites race and socioeconomic factors as influential in NSCLC patient survival rates

More information: Daniel Lin et al, Impact of socioeconomic status on survival for patients with anal cancer, Cancer (2018). DOI: 10.1002/cncr.31186

Related Stories

Study cites race and socioeconomic factors as influential in NSCLC patient survival rates

October 16, 2017
New research found race and specific socioeconomic factors to have a significant influence on disparities in the survival rates of non-small cell lung cancer (NSCLC) patients. Dr. Yanyan Lou of the Mayo Clinic in the United ...

Study uncovers healthcare disparities among octogenarians and nonagenarians with advanced lung cancer

January 8, 2018
A new study reveals that, among patients of advanced age with stage III lung cancer, African Americans and individuals who live in lower income areas are more likely to not receive any treatment. Published early online in ...

Risk of HPV-linked second cancers up after anal cancer

June 15, 2017
(HealthDay)—Survivors of squamous cell carcinoma of the anus (SCCA) have an elevated risk of human papillomavirus (HPV)-related second primary malignancies (SPMs), according to a study published online June 13 in Cancer.

Small-cell lung cancer patients face barriers to receiving standard-of-care treatment

January 4, 2018
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients ...

Survival period for esophageal cancer is tied to race and income

January 27, 2016
African-American patients with esophageal cancer survive fewer months after diagnosis than white patients, but only if they also have low incomes, according to a new study from Duke Health researchers.

Sex, race, age disparities in survival for HPV-linked cancer

November 28, 2017
(HealthDay)—For patients with human papillomavirus (HPV)-associated cancers, there are large disparities in survival based on sex, race, and age, according to a study published online Nov. 6 in Cancer.

Recommended for you

DNA vaccine leads to immune responses in HPV-related head and neck cancer

September 21, 2018
A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus (HPV)-related head and neck cancer. Researchers from the Abramson Cancer Center of the University of ...

In zebrafish, a way to find new cancer therapies, targeting tumor modulators

September 21, 2018
The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes. Looking for a way to test for their presence in zebrafish, their go-to research ...

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.